Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 1006


Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 

    Article Cited by others


Hepatoprotective effects of select water-soluble PARP inhibitors in a carbon tetrachloride model

McCluskey James D, Sava Dmytro, Harbison Stephen C, Muro-Cacho Carlos A, Giffe Johnson T, Ping Xu, Harbison Raymond D

Year : 2011| Volume: 1| Issue : 2 | Page no: 97-103

   This article has been cited by
1 Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration
Ayse Sahaboglu,Maria Miranda,Denis Canjuga,Meltem Avci-Adali,Natalia Savytska,Enver Secer,Jessica Abigail Feria-Pliego,Gülru Kayik,Serdar Durdagi
Cellular and Molecular Life Sciences. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 PARP inhibition by olaparib alleviates chronic asthma-associated remodeling features via modulating inflammasome signaling in mice
Gurupreet S. Sethi,Sukriti Sharma,Amarjit S. Naura
IUBMB Life. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals
Esraa Zakaria,Hany El-Bassossy,Nabila El-Maraghi,Ahmed Fahmy,Abdelmonim Ali
European Journal of Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]
4 Ex vivoprotective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aß(1-42)
Ezgi Turunc Bayrakdar,Guliz Armagan,Yigit Uyanikgil,Lutfiye Kanit,Ersin Koylu,Ayfer Yalcin
Cell Biochemistry and Function. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]


Read this article